Chester County News and Community Website
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced it is exploring various strategic options to maximize stockholder value. This decision comes in the wake of financial challenges …
Helius Medical Technologies Considers Strategic Alternatives Amid Financial Challenges Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has voiced strong objections to the newly announced Medicare payment rates for its PoNS Mouthpiece, set by the Centers for Medicare & …
Helius Medical Technologies Challenges CMS Over PoNS Payment Rates Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq:HSDT) has announced promising preliminary findings from its PoNSTEP study, which evaluates the impact of adherence to the Portable Neuromodulation Stimulator (PoNS®) Therapy on …
Helius Medical Technologies Reports Positive Preliminary Results from PoNSTEP Study Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced the approval of equity awards under its 2021 Inducement Plan, effective August 14, 2024. The awards were granted as a …
Helius Medical Technologies Announces Equity Awards Under 2021 Inducement Plan Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq:HSDT) has announced its financial results for the quarter ended June 30, 2024, showcasing significant strides in both financial performance and business development. …
Helius Medical Technologies Reports Second Quarter 2024 Results and Major Milestones Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced the completion of site participation enrollment for its U.S. stroke registrational program. Newly added participants include REHABOLOGYM, Neurology Center of …
Helius Medical Completes Enrollment for U.S. Stroke Therapy Program Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced this week that it has secured its first third-party reimbursement from a major insurance carrier for its Portable Neuromodulation Stimulator …
Helius Medical Secures First Insurance Reimbursement for PoNS Device Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced its Portable Neuromodulation Stimulator (PoNS®) device has been approved for inclusion on Lovell Government Services’ Veterans Affairs (VA) Federal Supply …
Helius Medical’s PoNS Device Gains Federal Supply Schedule Approval Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) this week announced promising developments in its first quarter financial and operational update for 2024. The company reported progress on several …
Helius Medical Technologies Moves Closer to Medicare Reimbursement, Expands Stroke Program Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) is set to announce its financial outcomes for the first quarter of 2024 on Monday, May 13, after the market closure.
Helius Medical Technologies to Unveil Q1 2024 Results and Discuss PoNS® U.S. Commercialization Read More